Cognitive Dysfunction and Diabetes Mellitus

The deleterious effects of diabetes mellitus on the retinal, renal, cardiovascular, and peripheral nervous systems are widely acknowledged. Less attention has been given to the effect of diabetes on cognitive function. Both type 1 and type 2 diabetes mellitus have been associated with reduced performance on numerous domains of cognitive function. The exact pathophysiology of cognitive dysfunction in diabetes is not completely understood, but it is likely that hyperglycemia, vascular disease, hypoglycemia, and insulin resistance play significant roles. Modalities to study the effect of diabetes on the brain have evolved over the years, including neurocognitive testing, evoked response potentials, and magnetic resonance imaging. Although much insightful research has examined cognitive dysfunction in patients with diabetes, more needs to be understood about the mechanisms and natural history of this complication in order to develop strategies for prevention and treatment.

[1]  I. Lieberburg,et al.  This paper was presented at the National Academy of Sciences colloquium ''Proteolytic Processing and Physiological Regulation,'' held February 20-21, 1999, at the Arnold and Mabel Beckman Center in Irvine, CA. Cellular mechanisms of b-amyloid production and secretion , 1999 .

[2]  R. Sheeladevi,et al.  PKC-α mediated alterations of indoleamine contents in diabetic rat brain , 2004, Brain Research Bulletin.

[3]  Effects of Intensive Diabetes Therapy on Neuropsychological Function in Adults in the Diabetes Control and Complications Trial , 1996, Annals of Internal Medicine.

[4]  Y. Ohashi,et al.  Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J‐EDIT) , 2006, Diabetes/metabolism research and reviews.

[5]  Barbara L. Welther,et al.  The impact , 1995 .

[6]  S. Waxman,et al.  The brain in diabetes: molecular changes in neurons and their implications for end-organ damage , 2003, The Lancet Neurology.

[7]  P. Cleary,et al.  Long-term effect of diabetes and its treatment on cognitive function. , 2007, The New England journal of medicine.

[8]  N. Inestrosa,et al.  Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling , 2005 .

[9]  F. Barkhof,et al.  Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy , 2006, Diabetologia.

[10]  M. Uldry,et al.  GLUTX1, a Novel Mammalian Glucose Transporter Expressed in the Central Nervous System and Insulin-sensitive Tissues* , 2000, The Journal of Biological Chemistry.

[11]  H. Dorchy,et al.  EEG Abnormalities in Diabetic Children , 1979, Clinical pediatrics.

[12]  Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. , 1993 .

[13]  B. de Strooper,et al.  Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide , 2004, The Journal of Neuroscience.

[14]  C. Messier.  Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging , 2005, Neurobiology of Aging.

[15]  T. Wieloch.  Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. , 1985, Science.

[16]  J. Pumprla,et al.  Decrease of vigilance assessed by EEG-mapping in Type I diabetic patients with history of recurrent severe hypoglycaemia , 2000, Psychoneuroendocrinology.

[17]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[18]  K. Jellinger,et al.  Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin‐6 in Alzheimer's disease patients , 2001, Acta neurologica Scandinavica.

[19]  Bruce A. Yankner,et al.  Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus , 1994, Nature.

[20]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[21]  G. Schellenberg,et al.  Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease , 1998, Neurology.

[22]  D. Simonson,et al.  Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. , 1990, Annals of internal medicine.

[23]  E. Barrett-Connor,et al.  Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. , 2004, Archives of internal medicine.

[24]  N. Day,et al.  Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.

[25]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[26]  P. Schwartz.  SENILE CEREBRAL, PANCREATIC INSULAR AND CARDIAC AMYLOIDOSIS. , 1965, Transactions of the New York Academy of Sciences.

[27]  L. Molinari,et al.  Impaired intellectual development in children with Type I diabetes: association with HbA1 c, age at diagnosis and sex , 2002, Diabetologia.

[28]  J. Heitner,et al.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects , 1997, Neurology.

[29]  C. Ryan.  Memory and metabolic control in children. , 1999, Diabetes care.

[30]  M. Marmot,et al.  Diabetes and cognitive function in a middle-aged cohort , 2005, Neurology.

[31]  Schwartz,et al.  Basal cortisol levels and cognitive deficits in human aging , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  M. Franceschi,et al.  Clinical and epidemiological aspects of Alzheimer??s disease with presenile onset: a case control study , 1991 .

[33]  T. Shiga,et al.  Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT. , 2006, Diabetes research and clinical practice.

[34]  L. Dorfman,et al.  Spinal somatosensory conduction in diabetes , 1981, Neurology.

[35]  D. Fedele,et al.  Auditory brainstem evoked responses in the clinical evaluation and follow-up of insulin-dependent diabetic subjects. , 1987, Acta oto-laryngologica.

[36]  G. di Chiro,et al.  Decreased brain glucose utilization in patients with Cushing's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  Ronald C Petersen,et al.  Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.

[38]  Johanna Kuusisto,et al.  Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study , 1997, BMJ.

[39]  E. Bigler,et al.  Neuropsychological findings in diabetes mellitus. , 1984, Journal of clinical psychology.

[40]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[41]  I. Deary.  Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetic patients , 1993 .

[42]  Frederik Barkhof,et al.  Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. , 2006, Diabetes.

[43]  P. Reichard,et al.  Intensified conventional insulin treatment and neuropsychological impairment. , 1991, BMJ.

[44]  P. O'Brien,et al.  Risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997, American journal of epidemiology.

[45]  In Kyoon Lyoo,et al.  Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. , 2006, Diabetes.

[46]  A. Sima,et al.  Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes , 2007, Diabetes.

[47]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.

[48]  D. Porte,et al.  Localization of insulin receptor mRNA in rat brain by in situ hybridization. , 1990, Endocrinology.

[49]  M. Raizada,et al.  Insulin inhibits pyramidal neurons in hippocampal slices , 1984, Brain Research.

[50]  P. J. Koudstaal,et al.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.

[51]  W. Tasman,et al.  Proliferative retinopathy: absence of white matter lesions at MR imaging. , 1991, Radiology.

[52]  G. Milligan,et al.  Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. , 1993, Biochemical and biophysical research communications.

[53]  W. Lockette,et al.  α2-Adrenergic Agonists Increase Cellular Lactate Efflux , 1996 .

[54]  I. Deary,et al.  The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes , 2006, Diabetologia.

[55]  R. Duckrow,et al.  Regional cerebral blood flow decreases during chronic and acute hyperglycemia. , 1987, Stroke.

[56]  O T Wolf,et al.  Hippocampal volume and cognitive performance in long‐standing Type 1 diabetic patients without macrovascular complications , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[57]  G. Biessels,et al.  Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression , 1999, Neuroscience.

[58]  A. Kurita,et al.  Neurophysiological evidence for altered higher brain functions in NIDDM. , 1996 .

[59]  C. Pavlides,et al.  Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field , 1999, Brain Research.

[60]  P. Marsden,et al.  The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. , 2002, Diabetes.

[61]  M. Catalano,et al.  Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. , 2005, Endocrinology.

[62]  S. Kuroda,et al.  Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species , 2006, Brain Research.

[63]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[64]  Thomas Klockgether,et al.  Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice , 2005 .

[65]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[66]  I. Deary,et al.  Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. , 2003, Diabetes care.

[67]  I. Deary,et al.  Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. , 2003, Diabetes.

[68]  K. Yaffe,et al.  Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. , 2006, The journal of nutrition, health & aging.

[69]  L. Bouter,et al.  Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.

[70]  J. Newcomer,et al.  Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. , 1993, Behavioral neuroscience.

[71]  P. Davies,et al.  Troglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, decreases tau phosphorylation in CHOtau4R cells , 2006, Journal of neurochemistry.

[72]  G. Biessels,et al.  Ageing and diabetes: implications for brain function. , 2002, European journal of pharmacology.

[73]  R. Gruetter,et al.  The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. , 2001, Diabetes.

[74]  Elizabeth Gould,et al.  Stress and hippocampal neurogenesis , 1999, Biological Psychiatry.

[75]  C. Holmes.  Neuropsychological profiles in men with insulin-dependent diabetes. , 1986 .

[76]  Bryon A Mueller,et al.  Diffusion tensor imaging in children with fetal alcohol spectrum disorders. , 2006, Alcoholism, clinical and experimental research.

[77]  S. Butler,et al.  The clinical role of evoked potentials , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[78]  T. Hershey,et al.  Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. , 1999, Diabetes care.

[79]  Alberto Pupi,et al.  Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[80]  R. Traystman,et al.  Gender-based Differences in Na+–K+ Adenosine Triphosphatase Activity Occur in the Microcirculation of the Diabetic Rat Brain , 2001, Anesthesiology.

[81]  D. Singer,et al.  Decreased cognitive function in aging non-insulin-dependent diabetic patients. , 1984, The American journal of medicine.

[82]  J. Newcomer,et al.  Decreased memory performance in healthy humans induced by stress-level cortisol treatment. , 1999, Archives of general psychiatry.

[83]  G. Moneta,et al.  Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes , 2007 .

[84]  P Ducimetière,et al.  Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. , 2001, Diabetes care.

[85]  P. Prior,et al.  Effect of Antecedent Glucose Control on Cerebral Function During Hypoglycemia , 1991, Diabetes Care.

[86]  B. Siesjö,et al.  Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. , 2000, Stroke.

[87]  B. Roozendaal,et al.  Acute cortisone administration impairs retrieval of long-term declarative memory in humans , 2000, Nature Neuroscience.

[88]  T. Takao,et al.  Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus. , 1996, Endocrine journal.

[89]  W. Weil,et al.  Intelligence of children with diabetes mellitus. , 1961, Pediatrics.

[90]  G. Pozzessere,et al.  Early Detection of Neurological Involvement in IDDM and NIDDM: Multimodal Evoked Potentials Versus Metabolic Control , 1988, Diabetes Care.

[91]  Jan Born,et al.  Intranasal insulin improves memory in humans , 2004, Psychoneuroendocrinology.

[92]  R. Sapolsky,et al.  Hippocampal damage associated with prolonged glucocorticoid exposure in primates , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[93]  B. McEwen,et al.  Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Daniel J Cox,et al.  Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. , 2005, Diabetes care.

[95]  S. Marenco,et al.  Regional Cerebral Blood Flow and Cerebrovascular Reactivity in IDDM , 1993, Diabetes Care.

[96]  J. Manson,et al.  Type 2 diabetes and cognitive function in community-dwelling elderly women. , 2001, Diabetes care.

[97]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[98]  E. Northam,et al.  Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. , 2001, Diabetes care.

[99]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[100]  A. Mochizuki,et al.  Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease , 2000, The Lancet.

[101]  D. Selkoe,et al.  Neurons Regulate Extracellular Levels of Amyloid β-Protein via Proteolysis by Insulin-Degrading Enzyme , 2000, The Journal of Neuroscience.

[102]  A. McCall.  The Impact of Diabetes on the CNS , 1992, Diabetes.

[103]  H. Koehn,et al.  New approaches in nuclear medicine for early diagnosis of Alzheimer's disease. , 2004, Current Alzheimer research.

[104]  J. Rovet,et al.  Attentional Functioning in Children and Adolescents With IDDM , 1997, Diabetes Care.

[105]  L. Wecker,et al.  Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain , 1991, Neurochemical Research.

[106]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[107]  I. Deary,et al.  Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. , 2004, Diabetes care.

[108]  A D Roses,et al.  Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease , 2006, The Pharmacogenomics Journal.

[109]  J. Gade,et al.  Cognitive function in Type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia , 1992, Diabetologia.

[110]  A. Sima,et al.  The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. , 2005, Diabetes.

[111]  G. Perry,et al.  Chitin-like polysaccharides in Alzheimer's disease brains. , 2005, Current Alzheimer research.

[112]  T. Hershey,et al.  Memory and insulin dependent diabetes mellitus (IDDM): Effects of childhood onset and severe hypoglycemia , 1997, Journal of the International Neuropsychological Society.

[113]  J. Chan,et al.  Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. , 1999, Diabetes care.

[114]  J. Williamson,et al.  Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies , 2005, Diabetologia.

[115]  A Parving,et al.  Evidence for Diabetic Encephalopathy , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[116]  C. Ryan,et al.  Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. , 2000, Diabetes care.

[117]  G. Comi.  Evoked potentials in diabetes mellitus. , 1997, Clinical neuroscience.

[118]  A. Drash,et al.  Cognitive deficits in adolescents who developed diabetes early in life. , 1985, Pediatrics.

[119]  M. Joëls,et al.  Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. , 1989, Science.

[120]  W. Honer,et al.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.

[121]  M. Bennett,et al.  Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[122]  P. Johnson,et al.  Thickened cerebral cortical capillary basement membranes in diabetics. , 1982, Archives of pathology & laboratory medicine.

[123]  P. E. Gold,et al.  Blood glucose and brain function: interactions with CNS cholinergic systems. , 1988, Behavioral and neural biology.

[124]  Ryan.  Effects of Diabetes Mellitus on Neuropsychological Functioning: A Lifespan Perspective. , 1997, Seminars in clinical neuropsychiatry.

[125]  K Yaffe,et al.  Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. , 2000, Archives of internal medicine.

[126]  A. Maran,et al.  Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects , 2000, Diabetologia.

[127]  B. Teter,et al.  Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention , 2004, The Journal of Neuroscience.

[128]  S. Pappatà,et al.  Brain metabolism after recurrent insulin induced hypoglycaemic episodes: a PET study. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[129]  I. Deary,et al.  Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. , 1999, Diabetes care.

[130]  Sanjay Asthana,et al.  Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender , 1999, Neuroendocrinology.

[131]  Geert Jan Biessels,et al.  Cognitive Performance, Psychological Well-Being, and Brain Magnetic Resonance Imaging in Older Patients With Type 1 Diabetes , 2006, Diabetes.

[132]  R. Nesto,et al.  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials , 2007, The Lancet.

[133]  K. Perryman,et al.  Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. , 1988, Archives of internal medicine.

[134]  B. M. Lobnig,et al.  Hippocampal volume and cognitive performance in long‐standing Type 1 diabetic patients without macrovascular complications , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[135]  K. Tracey,et al.  Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[136]  J. Newcomer,et al.  Glucocorticoid-induced impairment in declarative memory performance in adult humans , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[137]  A. Maran,et al.  Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM , 1995, Diabetologia.

[138]  A. D. Williams.  Psychometric concerns in neuropsychological testing. , 2001, NeuroRehabilitation.

[139]  W. H. Gispen,et al.  Cerebral function in diabetes mellitus , 1994, Diabetologia.

[140]  F. Barkhof,et al.  Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume , 2007, Diabetologia.

[141]  K. Akiyama,et al.  Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type , 1991, Biological Psychiatry.

[142]  PSYCHOLOGIC TESTS APPLIED TO DIABETIC PATIENTS , 1922 .

[143]  M. Reger,et al.  Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[144]  J. Born,et al.  Improving Influence of Insulin on Cognitive Functions in Humans , 2001, Neuroendocrinology.

[145]  J Suckling,et al.  The effect of acute hypoglycemia on brain function and activation: a functional magnetic resonance imaging study. , 2001, Diabetes.

[146]  R. Buchert,et al.  Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET , 2006, Nuclear medicine communications.

[147]  C. L. Yau,et al.  A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. , 2001, Diabetes care.

[148]  A. Antal,et al.  Lactate infusion fails to improve semantic categorization in Alzheimer's disease , 2005, Brain Research Bulletin.

[149]  C. Ryan.  Neurobehavioral Complications of Type I Diabetes: Examination of Possible Risk Factors , 1988, Diabetes Care.

[150]  P. Renshaw,et al.  The effects of type 1 diabetes on cerebral white matter , 2008, Diabetologia.

[151]  S. Levander,et al.  Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man , 1990, Diabetologia.

[152]  H. Cohen,et al.  Cognitive decline in patients with Cushing's syndrome , 2000, Journal of the International Neuropsychological Society.

[153]  H. Heinze,et al.  Impairment and recovery of elementary cognitive function induced by hypoglycemia in type-1 diabetic patients and healthy controls. , 2000, The Journal of clinical endocrinology and metabolism.

[154]  C. Cotman,et al.  Apolipoprotein‐E Genotyping of Diabetic Dementia Patients: Is Diabetes Rare in Alzheimer's Disease? , 1996, Journal of the American Geriatrics Society.

[155]  R. Kalaria,et al.  Nϵ-Carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease , 2004 .

[156]  T. Harris,et al.  Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance , 1999, Neurology.

[157]  G. Landreth.  PPARγ agonists as new therapeutic agents for the treatment of Alzheimer's disease , 2006, Experimental Neurology.

[158]  P. Barber,et al.  Diabetes, leukoencephalopathy and rage , 2006, Neurobiology of Disease.

[159]  S. Craft,et al.  Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice , 2006, Experimental Neurology.

[160]  D. Andrewes,et al.  Neuropsychological Complications of IDDM in Children 2 Years After Disease Onset , 1998, Diabetes Care.

[161]  A. Hofman,et al.  Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. , 2001, The Journal of clinical endocrinology and metabolism.

[162]  M. Goedert.  Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. , 1987, The EMBO journal.

[163]  Nunzio Pomara,et al.  Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study , 2002, Biological Psychiatry.

[164]  A. Alavi,et al.  Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome , 1990, Annals of neurology.

[165]  T. Orchard,et al.  Cognitive dysfunction in adults with Type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications , 1993, Diabetologia.

[166]  G. Schellenberg,et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.

[167]  O. Sabri,et al.  Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow , 2000, Nuclear medicine communications.

[168]  Y. Sheline,et al.  Memory improvement following induced hyperinsulinemia in alzheimer's disease , 1996, Neurobiology of Aging.

[169]  R. Moxley,et al.  Distribution of insulin receptor-like immunoreactivity in the rat forebrain , 1989, Neuroscience.

[170]  S. Craft,et al.  The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease , 2003, CNS drugs.

[171]  C. Behl,et al.  Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[172]  A. Schmidt,et al.  What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose , 1997, European journal of clinical investigation.

[173]  J. Foster,et al.  Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. , 2003, Diabetes research and clinical practice.

[174]  Ying Cui,et al.  GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[175]  Paul K. Marsden,et al.  Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance , 2006, Diabetes.

[176]  D. Dunger,et al.  Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes , 1999, Archives of disease in childhood.

[177]  O B Paulson,et al.  No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. , 1999, Diabetes.

[178]  K. Blennow,et al.  Low blood pressure and blood glucose levels in Alzheimer's disease Evidence for a hypometabolic disorder? , 1993, Journal of internal medicine.

[179]  R. Kalaria,et al.  ABNORMALITIES OF THE GLUCOSE TRANSPORTER AT THE BLOOD‐BRAIN BARRIER AND IN THE BRAIN IN ALZHEIMER'S DISEASE , 1989, Progress in clinical and biological research.

[180]  S. Hoyer,et al.  Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis , 1998, Journal of Neural Transmission.

[181]  E. Seaquist,et al.  Effect of Insulin on the Brain Activity Obtained during Visual and Memory Tasks in Healthy Human Subjects , 2006, Neuroendocrinology.

[182]  C. Holmes.  Neuropsychological profiles in men with insulin-dependent diabetes. , 1986, Journal of consulting and clinical psychology.

[183]  A. Rush,et al.  Hippocampal Remodeling and Damage by Corticosteroids: Implications for Mood Disorders , 1999, Neuropsychopharmacology.

[184]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[185]  C. Elberling,et al.  Hearing disorders in patients with insulin-dependent diabetes mellitus. , 1990, Audiology : official organ of the International Society of Audiology.

[186]  T. Orchard,et al.  Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications , 2003, Diabetologia.

[187]  L. Sokoloff,et al.  Effects of insulin on hexose transport across blood-brain barrier in normoglycemia. , 1987, The American journal of physiology.

[188]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[189]  Ryan Cm,et al.  Effects of Diabetes Mellitus on Neuropsychological Functioning: A Lifespan Perspective. , 1997 .

[190]  G. Reaven,et al.  Relationship Between Hyperglycemia and Cognitive Function in Older NIDDM Patients , 1990, Diabetes Care.

[191]  Roland N. Auer,et al.  Hypoglycemic Brain Damage , 2004, Metabolic Brain Disease.

[192]  Elizabeth A. Craig,et al.  Heat shock proteins and molecular chaperones: Mediators of protein conformation and turnover in the cell , 1994, Cell.

[193]  E. Wilander,et al.  The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus , 1978, Diabetologia.

[194]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[195]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[196]  B. Siesjö,et al.  Calcium Fluxes, Calcium Antagonists, and Calcium-Related Pathology in Brain Ischemia, Hypoglycemia, and Spreading Depression: A Unifying Hypothesis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[197]  M. Laakso,et al.  Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance , 1998, Diabetes Care.

[198]  A J Girling,et al.  Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. , 2000, Diabetes research and clinical practice.

[199]  B. Winblad,et al.  Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. , 2009, Acta medica Scandinavica.

[200]  S. Nissen,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[201]  Geert Jan Biessels,et al.  The effects of type 1 diabetes on cognitive performance: a meta-analysis. , 2005, Diabetes care.

[202]  I. Lieberburg,et al.  Cellular mechanisms of beta-amyloid production and secretion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[203]  J. Sredy,et al.  Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy. , 1991, The Journal of diabetic complications.

[204]  E. Reske‐Nielsen,et al.  Pathological changes in the central and peripheral nervous system of young long-term diabetics , 2005, Diabetologia.

[205]  J. Bauer,et al.  The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease , 1996, Behavioural Brain Research.

[206]  Arleen F. Brown,et al.  Cognitive and Physical Disabilities and Aging-Related Complications of Diabetes , 2003 .

[207]  P. E. Gold,et al.  Attenuation of scopolamine-induced amnesia in mice , 1988, Psychopharmacology.

[208]  R. Martins,et al.  Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype , 2000, Annals of the New York Academy of Sciences.

[209]  Sanjay Asthana,et al.  Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype , 2003, Psychoneuroendocrinology.

[210]  I. Campbell,et al.  Fatal Hypoglycaemia in Insulin‐treated Diabetes Mellitus: Clinical Features and Neuropathological Changes , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[211]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[212]  A. Bossuyt,et al.  Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes , 1996, European Journal of Nuclear Medicine.

[213]  F. Kaufman,et al.  Neurocognitive functioning in children diagnosed with diabetes before age 10 years. , 1999, Journal of diabetes and its complications.

[214]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[215]  P. Greengard,et al.  Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling , 2001, The Journal of Neuroscience.

[216]  Jeroen van der Grond,et al.  Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. , 2006, Diabetes.

[217]  W C Wiederholt,et al.  The Association of Non‐Insulin‐Dependent Diabetes Mellitus and Cognitive Function in an Older Cohort , 1998, Journal of the American Geriatrics Society.

[218]  信行 佐々木.  Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease , 2001 .

[219]  I. Deary,et al.  Brain Abnormalities Demonstrated by Magnetic Resonance Imaging in Adult IDDM Patients With and Without a History of Recurrent Severe Hypoglycemia , 1997, Diabetes Care.

[220]  I J Deary,et al.  Severe Hypoglycemia and Intelligence in Adult Patients With Insulin-Treated Diabetes , 1993, Diabetes.

[221]  H. B. Harvey,et al.  Effect of lactate therapy upon cognitive deficits after traumatic brain injury in the rat , 2007, Acta Neurochirurgica.

[222]  I. Deary,et al.  Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. , 2005, Diabetes care.

[223]  G. Wenk.  Neuropathologic changes in Alzheimer's disease: potential targets for treatment. , 2006, The Journal of clinical psychiatry.